Sfoglia per Autore
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
2007 Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; Colecchia A.
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation
2007 Piscaglia F, Gianstefani A, Ravaioli M, Sagrini E, Lodato F, Morelli C, Quarneti C, Giampalma E, Golfieri R, Pinna AD, Bolondi L
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
2007 Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Bernardi M; Andreone P.
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC.
2007 Ferrara F.; Lodato F.; Chieco P.; Mantovani V.; Colecchia A.; Roda E.; Brillanti S.
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid.
2007 Azzaroli F.; Mennone A.; Feletti V.; Simoni P.; Baglivo E.; Montagnani M.; Rizzo N.; Pelusi G.; DE Aloysio D.; Lodato F.; Festi D.; Colecchia A.; Roda E.; Boyer J.L.; Mazzella G.
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
2008 Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..]
Proton pump inhibitors in cirrhosis: tradition or evidence based practice?
2008 Lodato F; Azzaroli F; Di Girolamo M; Feletti V; Cecinato P; Lisotti A; Festi D; Roda E; Mazzella G.
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression
2008 D.Festi;F.Lodato;G.Mazzella;A.Colecchia
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence
2008 Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ; Roda E ; Mazzella G .
Outcomes and survival after TIPS positioning: a single center experience
2009 Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M, Mosconi C, Alessandrelli F, Mazzella G
Outcomes and survival after TIPS positioning: a single center experience
2009 Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M, Mosconi C, Alessandrelli F, Mazzella G
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE
2009 Buonfiglioli f; Azzaroli F; Montagnani M;Simoni P; Locatelli M; Raspanti ME; Lisotti A; Lodato F; Alessandrelli F; Colecchia A; Festi D; Roda A; Roda E; Mazzella G
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY
2009 F. Alessandrelli; F. Azzaroli; V. Feletti; A. Lisotti; F. Buonfiglioli; M. Montagnani; A. Colecchia; D. Festi; F. Lodato; E. Roda; G. Mazzella
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence
2009 Lodato F; Azzaroli F; Tamè MR; Di Girolamo M; Buonfiglioli F; Mazzella N; Cecinato P; Roda E; Mazzella G
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY
2010 F. Azzaroli; A. Mennone; M.E. Raspanti; M.L. Longo; M. Montagnani; L. Turco; F. Buonfiglioli; M. Giandinoto; F. Lodato; E. Roda; A. Lisotti; P. Cecinato; J.L.Boyer; G. Mazzella
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
2010 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Simoni P, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Adverse effects of proton pump inhibitors.
2010 Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G.
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study
2010 Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M; and Bologna Liver Transplantation Group.
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease.
2011 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis.
2011 Turco L, Azzaroli F, Buonfiglioli F, Lisotti A, Cecinato P, Montagnani M, Calvanese C, Lodato F, Golfieri R, Colecchia A, Festi D, Mazzella G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. | Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; C...olecchia A. | 2007-01-01 | CURRENT CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation | Piscaglia F, Gianstefani A, Ravaioli M, Sagrini E, Lodato F, Morelli C, Quarneti C, Giampalma E, ...Golfieri R, Pinna AD, Bolondi L | 2007-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? | Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia... F; Biselli M; Sama C; Mazzella G; Pinna AD; Bernardi M; Andreone P. | 2007-01-01 | GUT | - | 1.01 Articolo in rivista | - |
| Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. | Ferrara F.; Lodato F.; Chieco P.; Mantovani V.; Colecchia A.; Roda E.; Brillanti S. | 2007-01-01 | HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. | Azzaroli F.; Mennone A.; Feletti V.; Simoni P.; Baglivo E.; Montagnani M.; Rizzo N.; Pelusi G.; D...E Aloysio D.; Lodato F.; Festi D.; Colecchia A.; Roda E.; Boyer J.L.; Mazzella G. | 2007-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation | Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone ...P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..] | 2008-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Proton pump inhibitors in cirrhosis: tradition or evidence based practice? | Lodato F; Azzaroli F; Di Girolamo M; Feletti V; Cecinato P; Lisotti A; Festi D; Roda E; Mazzella G. | 2008-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression | D.Festi;F.Lodato;G.Mazzella;A.Colecchia | 2008-01-01 | - | Springer | 2.01 Capitolo / saggio in libro | - |
| G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence | Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ;... Roda E ; Mazzella G . | 2008-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Outcomes and survival after TIPS positioning: a single center experience | Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M,... Mosconi C, Alessandrelli F, Mazzella G | 2009-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Outcomes and survival after TIPS positioning: a single center experience | Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M,... Mosconi C, Alessandrelli F, Mazzella G | 2009-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE | Buonfiglioli f; Azzaroli F; Montagnani M;Simoni P; Locatelli M; Raspanti ME; Lisotti A; Lodato F;... Alessandrelli F; Colecchia A; Festi D; Roda A; Roda E; Mazzella G | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY | F. Alessandrelli; F. Azzaroli; V. Feletti; A. Lisotti; F. Buonfiglioli; M. Montagnani; A. Colecch...ia; D. Festi; F. Lodato; E. Roda; G. Mazzella | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence |
Lodato F; Azzaroli F; Tamè MR; Di Girolamo M; Buonfiglioli F; Mazzella N; Cecinato P; Roda E; Ma...zzella G |
2009-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY |
F. Azzaroli; A. Mennone; M.E. Raspanti; M.L. Longo; M. Montagnani; L. Turco; F. Buonfiglioli; M.... Giandinoto; F. Lodato; E. Roda; A. Lisotti; P. Cecinato; J.L.Boyer; G. Mazzella |
2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Simoni P, Cecinato P, Calvanese C, Lodato F, Mont...agnani M, Golfieri R, Colecchia A, Festi D, Mazzella G | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Adverse effects of proton pump inhibitors. | Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G. | 2010-01-01 | BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study | Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone ...P; Bernardi M; and Bologna Liver Transplantation Group. | 2010-01-01 | JOURNAL OF CLINICAL GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, ...Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | GASTROENTEROLOGY | - | 1.06 Abstract in rivista | - |
| Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. | Turco L, Azzaroli F, Buonfiglioli F, Lisotti A, Cecinato P, Montagnani M, Calvanese C, Lodato F, ...Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile